Xtant Medical Holdings Inc (XTNT):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Xtant Medical Holdings Inc (XTNT) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6641
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:52
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Xtant Medical Holdings Inc (Xtant Medical), formerly Bacterin International Holdings Inc, is a medical device company that develops regenerative medicine products and medical devices. The company’s products include 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for manufacturing bacterin products. The company offers its products for the treatment of degenerative, traumatic, and deformity conditions for orthopedic and neurological applications. It operates in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

Xtant Medical Holdings Inc (XTNT) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Xtant Medical Holdings Inc, Medical Equipment, Deal Details 11
Partnerships 11
Xtant Medical Enters into Licensing Agreement with Sites Medical 11
X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12
Xtant Medical Enters into Distribution Agreement with Curasan 13
Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14
Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15
Xtant Medical Enters into Agreement with Montana State University 16
Equity Offering 17
Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 17
Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18
Bacterin International Raises USD6.5 Million in Public Offering of Shares 20
Bacterin International Completes Private Placement Of Shares For US$4 Million 22
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 23
Xtant Medical Raises USD4.8 Million in Private Placement of Shares 24
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 25
Debt Offering 26
Xtant Medical Raises USD65 Million in Private Placement of Notes 26
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 27
Acquisition 28
Bacterin International Acquires X-spine Systems 28
Xtant Medical Holdings Inc – Key Competitors 29
Xtant Medical Holdings Inc – Key Employees 30
Xtant Medical Holdings Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Recent Developments 32
Strategy And Business Planning 32
Oct 06, 2017: Xtant Medical Announces Consolidation of Fixation Operations to Montana and Closure of Dayton Facility 32
Financial Announcements 33
Aug 07, 2018: Xtant Medical announces second quarter 2018 financial results 33
May 08, 2018: Xtant Medical Announces First Quarter 2018 Financial Results 35
Apr 02, 2018: Xtant Announces Fourth Quarter and Year End 2017 Financial Results 37
Nov 21, 2017: Xtant Medical Reports Third Quarter 2017 Financial Results 40
Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 42
May 09, 2017: Xtant Medical Reports First Quarter Revenue of $22.1 million, 5% Growth Compared to the Prior Year Period 43
Mar 09, 2017: Xtant Medical Reports Record Fourth Quarter Revenue of $24.5 million, 10% Growth Compared to Prior Year Period 44
Jan 11, 2017: XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue & Adjusted EBITDA 46
Corporate Communications 47
Aug 20, 2018: Xtant Medical appoints Kathie Lenzen as Chief Financial Officer 47
Jul 10, 2018: Xtant Medical Names Kevin Brandt As Chief Commercial Officer 48
Feb 22, 2017: Xtant Medical Announces Appointment of Carl O’Connell to Permanent CEO 49
Jan 23, 2017: Xtant Medical CEO Dan Goldberger announces resignation 50
Product News 51
Oct 25, 2017: Xtant Medical to Feature Product Portfolio at the 2017 North American Spine Society Annual Meeting 51
Appendix 52
Methodology 52
About GlobalData 52
Contact Us 52
Disclaimer 52

List of Tables
Xtant Medical Holdings Inc, Medical Equipment, Key Facts, 2017 2
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Deals By Market, 2012 to YTD 2018 9
Xtant Medical Holdings Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Xtant Medical Enters into Licensing Agreement with Sites Medical 11
X-spine Systems Enters into Licensing Agreement with Zimmer Spine 12
Xtant Medical Enters into Distribution Agreement with Curasan 13
Xtant Medical Enters into Distribution Agreement with Pinnacle Spine 14
Xtant Medical Enters into Distribution Agreement with Vivex Biomedical 15
Xtant Medical Enters into Agreement with Montana State University 16
Xtant Medical to Raise up to USD8.2 Million in Rights Offering of Shares 17
Xtant Medical Amends Terms of Rights Offering of Units for USD11.3 Million 18
Bacterin International Raises USD6.5 Million in Public Offering of Shares 20
Bacterin International Completes Private Placement Of Shares For US$4 Million 22
Bacterin International Completes Private Placement Of Shares For US$4.8 Million 23
Xtant Medical Raises USD4.8 Million in Private Placement of Shares 24
Bacterin International Completes Private Placement Of Shares For US$3.9 Million 25
Xtant Medical Raises USD65 Million in Private Placement of Notes 26
Bacterin International Raises USD65 Million in Private Placement of 6% Notes Due 2021 27
Bacterin International Acquires X-spine Systems 28
Xtant Medical Holdings Inc, Key Competitors 29
Xtant Medical Holdings Inc, Key Employees 30
Xtant Medical Holdings Inc, Subsidiaries 31

List of Figures
Xtant Medical Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Xtant Medical Holdings Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Xtant Medical Holdings Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Xtant Medical Holdings Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Xtant Medical Holdings Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Xtant Medical Holdings Inc (XTNT):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Emisphere Technologies Inc (EMIS):企業の戦略的SWOT分析
    Emisphere Technologies Inc (EMIS) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Torrent Power Limited:発電所・企業SWOT分析
    Torrent Power Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Genuine Parts Company:企業の戦略・SWOT・財務分析
    Genuine Parts Company - Strategy, SWOT and Corporate Finance Report Summary Genuine Parts Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Emera (Caribbean) Inc.:企業の戦略的SWOT分析
    Emera (Caribbean) Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Beltrami Electric Cooperative Inc:企業の戦略的SWOT分析
    Beltrami Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Rottneros AB (RROS):企業の財務・戦略的SWOT分析
    Rottneros AB (RROS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Taikisha Ltd
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Star Gas Partners L.P.:企業の戦略・SWOT・財務分析
    Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report Summary Star Gas Partners L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Ophthotech Corp (OPHT):製薬・医療:M&Aディール及び事業提携情報
    Summary Ophthotech Corp (Ophthotech) is a biopharmaceutical company that offers novel therapeutics to treat diseases of the back of the eye for age-related macular degeneration. The company’s products include Zimura, an anti-complemente is a central component of the complement cascade that is suppos …
  • WNS (Holdings) Limited:企業の戦略・SWOT・財務情報
    WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary WNS (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Hitachi, Ltd.:企業のM&A・事業提携・投資動向
    Hitachi, Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hitachi, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Hutchison 3G UK Limited:企業の戦略・SWOT・財務分析
    Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report Summary Hutchison 3G UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Scilex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Scilex Pharmaceuticals Inc (Scilex Pharma), a subsidiary of Sorrento Therapeutics Inc is a developer of pharmaceutical products. The company develops and commercializes branded pharmaceutical products for the treatment of pain. Its technologies include drug delivery and proprietary patch tec …
  • ARC Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    ARC Resources Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary ARC Resources Ltd (ARC) is an energy company, which carries out exploration, development and production of conventional crude oil and natural gas reserves. Its produces light and medium crude oil, …
  • Fresenius Kidney Care:製薬・医療:M&Aディール及び事業提携情報
    Summary Fresenius Kidney Care (FMCNA), formerly Fresenius Medical Care Holdings Inc, a subsidiary of Fresenius Medical Care AG & Co KGaA, is a provider of dialysis services and renal care products. The company’s dialysis products include hemodialysis; dialyzers, haemodialysis machines, FMiS medical …
  • AES Gener SA (AESGENER):企業の財務・戦略的SWOT分析
    AES Gener SA (AESGENER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Surfnet:企業の戦略的SWOT分析
    Surfnet - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Hansen Technologies Ltd (HSN):企業の財務・戦略的SWOT分析
    Summary Hansen Technologies Ltd (Hansen Technologies) is a technology company that offers customer care, billing, and meter data management software solutions. The company provides outsourcing services such as facilities management, support center, consulting, host management, business continuity, i …
  • AECOM (ACM):石油・ガス:M&Aディール及び事業提携情報
    Summary AECOM, formerly AECOM Technology Corporation, is a provider of engineering, consulting and project management services. The company primarily designs, builds, operates and finances various infrastructure assets for businesses, governments, and organizations. Its service offerings include ass …
  • Genisphere LLC:医療機器:M&Aディール及び事業提携情報
    Summary Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆